Bridgeway Capital Management LLC Invests $141,000 in Quipt Home Medical Corp. (NASDAQ:QIPT)

Bridgeway Capital Management LLC acquired a new position in shares of Quipt Home Medical Corp. (NASDAQ:QIPT) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 46,300 shares of the company’s stock, valued at approximately $141,000.

Several other large investors have also modified their holdings of QIPT. Jane Street Group LLC boosted its stake in shares of Quipt Home Medical by 28.5% during the 3rd quarter. Jane Street Group LLC now owns 41,926 shares of the company’s stock worth $122,000 after acquiring an additional 9,290 shares in the last quarter. Barclays PLC boosted its stake in shares of Quipt Home Medical by 79.2% during the 3rd quarter. Barclays PLC now owns 87,425 shares of the company’s stock worth $256,000 after acquiring an additional 38,635 shares in the last quarter. Franklin Resources Inc. boosted its stake in shares of Quipt Home Medical by 8.7% during the 3rd quarter. Franklin Resources Inc. now owns 740,785 shares of the company’s stock worth $2,163,000 after acquiring an additional 59,441 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Quipt Home Medical by 68.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 30,403 shares of the company’s stock worth $89,000 after acquiring an additional 12,383 shares in the last quarter. Finally, Salem Investment Counselors Inc. boosted its stake in shares of Quipt Home Medical by 57.4% during the 4th quarter. Salem Investment Counselors Inc. now owns 74,000 shares of the company’s stock worth $226,000 after acquiring an additional 27,000 shares in the last quarter. 42.85% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group reissued a “hold” rating and set a $1.70 price objective (down from $4.00) on shares of Quipt Home Medical in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, two have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Quipt Home Medical has a consensus rating of “Moderate Buy” and a consensus price target of $5.18.

Quipt Home Medical Stock Performance

Shares of Quipt Home Medical stock opened at $1.67 on Wednesday. The stock has a market cap of $71.96 million, a PE ratio of -9.82 and a beta of 0.65. The business has a fifty day simple moving average of $2.19 and a 200-day simple moving average of $2.56. The company has a quick ratio of 0.87, a current ratio of 1.22 and a debt-to-equity ratio of 0.74. Quipt Home Medical Corp. has a 12 month low of $1.60 and a 12 month high of $4.17.

Quipt Home Medical (NASDAQ:QIPT) last issued its earnings results on Monday, May 12th. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.09). The business had revenue of $57.40 million during the quarter, compared to analyst estimates of $88.29 million. Quipt Home Medical had a negative return on equity of 6.70% and a negative net margin of 2.90%. On average, sell-side analysts anticipate that Quipt Home Medical Corp. will post -0.05 EPS for the current fiscal year.

Quipt Home Medical Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.